Literature DB >> 12419132

Modality-specific deterioration in naming verbs in nonfluent primary progressive aphasia.

Argye E Hillis1, Elizabeth Tuffiash, Alfonso Caramazza.   

Abstract

A longitudinal study of oral and written naming and comprehension of nouns and verbs in an individual (M. M. L.) with nonfluent primary progressive aphasia (PPA) is reported. M. M. L. showed progressive deterioration of oral naming of verbs well before deterioration of written naming of verbs and before deterioration of oral or written naming of nouns. Her comprehension of both nouns and verbs remained intact, at least relative to oral naming of verbs. Her performance is compared to that of two other individuals with nonfluent PPA, who were tested at two time points. These patients showed similar patterns with respect to grammatical word class (verbs more impaired than nouns) and modality (spoken production more impaired than written production), but somewhat different courses of deterioration. The modality-specific nature of the observed verb production deficits rules out a semantic locus for the grammatical class effects. The results provide a new source of evidence for the hypothesis that there are distinct neural mechanisms for accessing lexical representations of nouns and verbs in language production.

Entities:  

Mesh:

Year:  2002        PMID: 12419132     DOI: 10.1162/089892902320474544

Source DB:  PubMed          Journal:  J Cogn Neurosci        ISSN: 0898-929X            Impact factor:   3.225


  43 in total

1.  Neural correlates of semantic and morphological processing of Hebrew nouns and verbs.

Authors:  Dafna Palti; Michal Ben Shachar; Talma Hendler; Uri Hadar
Journal:  Hum Brain Mapp       Date:  2007-04       Impact factor: 5.038

2.  Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration.

Authors:  Katerina A Tetzloff; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Sarah M Boland; Rene L Utianski; Hugo Botha; Matthew L Senjem; Christopher G Schwarz; Keith A Josephs; Jennifer L Whitwell
Journal:  Neurocase       Date:  2018-05-25       Impact factor: 0.881

3.  Treatment of Primary Progressive Aphasia.

Authors:  Donna C Tippett; Argye E Hillis; Kyrana Tsapkini
Journal:  Curr Treat Options Neurol       Date:  2015-08       Impact factor: 3.598

Review 4.  Language mapping with verbs and sentences in awake surgery: a review.

Authors:  Adrià Rofes; Gabriele Miceli
Journal:  Neuropsychol Rev       Date:  2014-04-16       Impact factor: 7.444

5.  Quantitative Analysis of Agrammatism in Agrammatic Primary Progressive Aphasia and Dominant Apraxia of Speech.

Authors:  Katerina A Tetzloff; Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Keith A Josephs; Jennifer L Whitwell
Journal:  J Speech Lang Hear Res       Date:  2018-09-19       Impact factor: 2.297

6.  Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.

Authors:  Gil D Rabinovici; William J Jagust; Ansgar J Furst; Jennifer M Ogar; Caroline A Racine; Elizabeth C Mormino; James P O'Neil; Rayhan A Lal; Nina F Dronkers; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

7.  Grammatical Impairments in PPA.

Authors:  Cynthia K Thompson; Jennifer E Mack
Journal:  Aphasiology       Date:  2014-09       Impact factor: 2.773

8.  Verb generation in children with spina bifida.

Authors:  Maureen Dennis; Derryn Jewell; Ross Hetherington; Christine Burton; Michael E Brandt; Susan E Blaser; Jack M Fletcher
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

Review 9.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 10.  Primary progressive aphasia and the evolving neurology of the language network.

Authors:  M-Marsel Mesulam; Emily J Rogalski; Christina Wieneke; Robert S Hurley; Changiz Geula; Eileen H Bigio; Cynthia K Thompson; Sandra Weintraub
Journal:  Nat Rev Neurol       Date:  2014-09-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.